Last reviewed · How we verify
NCT03614754
Sacral Neuromodulation and Pudendal Somatic Afferents
trial testing Somatosensory evoked potentials in Overactive Bladder, Non Obstructive Urinary Retention in 40 participants. Status unknown.
31 July 2022
Quick facts
| Lead sponsor | Universiteit Antwerpen |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 August 2017 |
| Primary completion | 31 July 2022 |
| Estimated completion | 31 July 2022 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Somatosensory evoked potentials
Conditions studied
- Overactive Bladder, Non Obstructive Urinary Retention — all drugs for Overactive Bladder, Non Obstructive Urinary Retention →
Sponsor
Universiteit Antwerpen — full company profile →
Who can join
18 and older, any sex, with Overactive Bladder, Non Obstructive Urinary Retention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sacral neuromodulation is a well-excepted minimally invasive procedure for the treatment of overactive bladder and non-obstructive urinary retention.A tined lead with 4 stimulation electrodes is placed through the third or fourth sacral foramen and stimulates sacral roots in its vicinity. Since the sacral roots are mixed nerves, it is currently still unknown which nerve fibers are stimulated (autonomic vs somatic, afferent vs efferent) and what the mechanism of action is. This study examines the involvement of pudendal somatic afferents by measuring somatosensory evoked potentials elicited by stimulation of the pudendal nerve.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03614754
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Somatosensory evoked potentials
Trials testing the same drug.
- NCT06491823 — Speech Motor Learning and Retention (Aim 2) · NA · recruiting
Other Universiteit Antwerpen trials
Trials by the same sponsor.
- NCT07407569 — Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H · Phase 2 · recruiting
- NCT07355101 — Personalized Exercise Coaching to Improve Quality of Life in Pediatric IBD · NA · active not recruiting
- NCT06962579 — The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy · NA · recruiting
- NCT06999473 — Assessment and Treat Neglect Patients With a VR Application · NA · not yet recruiting
- NCT07161531 — Test-retest Reliability of sEMG to Measure Fatigue in Adolescents · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03614754 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universiteit Antwerpen
- Last refreshed: 15 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03614754.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing